Claro has now joined forces with Regemat 3D (a biotech company pioneer in the design and development of customized 3D bioprinters and bioreactors for research in the regenerative medicine field), which will now distribute Claro’s BG800 that was developed for extrusion-based bioprinters.
Claro acknowledges that bioprinting will help periodontal therapy advance
Periodontal (gum) disease: an annual cost estimated at 79 billion euros in Europe
Periodontal (gum) disease is extremely common. Severe periodontal diseases are found in 5–20% of middle-aged (35–44 years) adults in Europe, and up to 40% of older people (65–74 years). Diseases of the mouth are an expensive burden to health care services.
GelMA by Claro: great potential to build 3D models that mimic real tumors
The need for innovative 3D cancer models to enhance drug-testing process
The National Cancer Institute defines cancer as “a term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems.” [1]. Metastases are the primary...
